Amgen appoints regulatory affairs and safety specialist Amgen appoints regulatory affairs and safety specialist Steven Galson gains a promotion GenSight Biologics appoints Jean-Philippe Combal as Chief Operating Officer GenSight Biologics appoints Jean-Philippe Combal as Chief Operating Officer He brings extensive experience in ophthalmologic diseases to the French company Sven Andreasson joins Novavax as SVP of Corporate Development Sven Andreasson joins Novavax as SVP of Corporate Development Formerly CEO of Isconova, which was acquired by Novavax last year Midatech makes two appointments Midatech makes two appointments Strengthening the Board and senior management team Astellas makes a promotion and a new appointment Astellas makes a promotion and a new appointment In Global Development and Global Medical Affairs Kenneth Sommerville joins GW Pharmaceuticals as VP of Clinical Science Kenneth Sommerville joins GW Pharmaceuticals as VP of Clinical Science To support US medical affairs and regulatory activities related to epilepsy programmes Sygnature Discovery hires Director of Business Development Sygnature Discovery hires Director of Business Development Dr Gerry Thomas joins the company Juergen Hambrecht becomes Chairman of BASF Supervisory Board Juergen Hambrecht becomes Chairman of BASF Supervisory Board Succeeding Eggert Voscherau Daniel Smith rejoins Cobra Biologics as Chief Scientific Officer Daniel Smith rejoins Cobra Biologics as Chief Scientific Officer After four years at the UK\'s HealthTech & Medicines KTN Enterome appoints Alessandra Cervino as Head of Discovery Enterome appoints Alessandra Cervino as Head of Discovery Brings genetic and genomic biomarkers experience to the company Sally Adams joins Scancell Holdings Board as Development Director Sally Adams joins Scancell Holdings Board as Development Director With 25 years of industry experience Recipharm makes three appointments to strengthen European sales drive Recipharm makes three appointments to strengthen European sales drive Adds two Business Management Directors and a Key Account Director for the Nordic region SGS appoints new oncology medical director SGS appoints new oncology medical director István Udvaros will support the sales, clinical pharmacology, clinical trial management and biometrics teams Lonza appoints new COO for Pharma & Biotech business Lonza appoints new COO for Pharma & Biotech business Marc Funk will take over following departure of Stephan Kutzer Ashland Chairman and Chief Executive Jim O\'Brien to retire Ashland Chairman and Chief Executive Jim O\'Brien to retire Board begins process to choose his successor Lupin Pharmaceuticals appoints Theresa Stevens as Chief Corporate Development Officer Lupin Pharmaceuticals appoints Theresa Stevens as Chief Corporate Development Officer Brings more than 27 years of experience in the pharmaceutical and biotech sector to the company